Cannabis therapy is safe and effective among elderly patients diagnosed with chronic pain, according to clinical data published online ahead of print in the European Journal of Internal Medicine. “After six months of treatment, 93.7 percent of the respondents reported improvement in their condition,” researchers reported.
Chronic pain patients enrolled in a statewide medical cannabis access program are significantly more likely to either reduce or cease their use of opioids as compared to non-enrolled patients suffering from similar pain conditions, according to data published online in the journal PLOS One.
Despite the growing body of scientific evidence showing that cannabis access is associated with reductions in opioid use and mortality, the Chairman of the White House’s Commission on Combating Drug Addiction and the Opioid Crisis today called upon the President to reject any efforts to acknowledge marijuana’s promising role in mitigating opioid abuse and dependency.
On Wednesday, October 11th, Congressional Cannabis Caucus Co-Chair Earl Blumenauer (D-OR) testified before the House Energy & Commerce Subcommittee on Health on how to deal with the opioid crisis in America.
Chronic pain patients enrolled in a statewide medical marijuana program are more likely to reduce their use of prescription drugs than are those patients who don’t use cannabis, according to data published online ahead of print in the Journal of Post-Acute and Long-Term Care Medicine.
Giving remarks to the Native American Housing Association, Housing and Urban Development Secretary Ben Carson strayed into the marijuana reform debate. Unfortunately, the doctor did not know his facts.
The initial recommendations are completely silent to the fact that medical marijuana access is associated with reduced rates of opioid use and abuse, opioid-related hospitalizations, opioid-related traffic fatalities, and opioid-related overdose deaths.
Pain patients report successfully substituting cannabis for opioids and other analgesics, according to data published online today in the journal Cannabis and Cannabinoid Research. Among those who acknowledged having used opioid-based pain medication within the past six months, 97 percent agreed that they were able to decrease their opiate intake with cannabis.
Just under half of respondents (46 percent) reported using cannabis in place of prescription medications. Respondents were most likely to use cannabis in lieu of narcotics/opioids (36 percent), anxiolytics/benzodiazepenes (14 percent), and antidepressants (13 percent).
Medical cannabis administration is associated with improved cognitive performance and lower levels of prescription drug use, according to longitudinal data published online in the journal Frontiers in Pharmacology.